The Claim
In rat models, nerve growth factor (NGF) is produced by muscle and/or satellite cells following lengthening contractions, and this NGF contributes to mechanical hyperalgesia associated with delayed onset muscle soreness (DOMS); intramuscular administration of an anti-NGF antibody reverses established DOMS within 3 hours, and upregulation of NGF mRNA is prevented by B2 bradykinin receptor antagonism, indicating that NGF acts as a downstream mediator in the DOMS pathway.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats, sore muscles after unusual exercise make a protein called NGF, which seems to cause pain sensitivity—blocking NGF quickly reduces soreness, and stopping another pain-related signal (bradykinin) also stops NGF from being made, suggesting it's part of the soreness chain reaction.
See the scientific wording
In rat models, nerve growth factor (NGF) is produced by muscle and/or satellite cells following lengthening contractions and contributes to mechanical hyperalgesia, as intramuscular injection of anti-NGF antibody reverses established DOMS within 3 hours, and NGF mRNA upregulation is blocked by B2 bradykinin receptor antagonism, indicating NGF is a downstream mediator in the DOMS pathway.
What the research says
1 studyStudy: Neurochemical mechanism of muscular pain: Insight from the study on delayed onset muscle soreness
The study shows that NGF plays a key role in muscle soreness after exercise in rats, and that it's activated by another pain-related molecule, which supports the idea that blocking NGF could reduce soreness.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.